# LOTEPREDNOL ETABONATE
> **ANDA215719** · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2024-04-24
## Drug
- **FDA Application Number:** ANDA215719
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LOTEPREDNOL ETABONATE
- **Generic name:** LOTEPREDNOL ETABONATE
- **Active ingredients:** LOTEPREDNOL ETABONATE
- **Dosage form:** SUSPENSION/DROPS
- **Route:** OPHTHALMIC
- **Marketing status:** Prescription
- **Sponsor:** LUPIN
- **Manufacturer:** Lupin Pharmaceuticals, Inc.
- **First approval:** 2024-04-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215719)
---
*MORVS · CC0 1.0*